Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia

IRB/UVA Tracking #
21188
Contact
Contact Phone
Phase
III
Primary purpose
Treatment
Cancer PI
Michael Keng
Status
OPEN TO ACCRUAL
Ages
Adult